ARQT
Arcutis Biotherapeutics, Inc.26.01post−$0.02 (−0.08%)at close +$0.09 (+0.35%)
as of 19:59:57 UTCnext report Aug 10 · 5d
Earnings Room‹ back to ARQT
The report
fiscal Q2 2026 · from the company's noticeAug 10after close5days out
Expected movement
market-implied · at the Aug 4 close±17.5%is what the chain prices between now and the expiry below. Not a view we hold.
That span is 17days, so it covers the report plus the ordinary movement around it. The chain doesn't yet quote a second expiry we can separate the two with; the range narrows onto the report as it approaches.
expiry Aug 21 · first after the reportATM strike 25straddle 5.35ATM IV 121%× 0.85 straddle-to-rangespot 26.01
Blast radius
3 linked · N-PORT + EDGARIf ARQT moves ±17.5% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are ranked by disclosed tie strength.
Positioning
Butterfly LadderNo options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.
The record
expected in pale · actual in full color1/8reports moved further than the options market had pricedtypically ±9.2% realized vs ±13.3% priced
Feb 25 '26±13.1%→+5.8%×0.44
Oct 28 '25±15.7%→+27.0%×1.72
Aug 6 '25±10.0%→−8.1%×0.81
May 6 '25±15.5%→−4.3%×0.28
Feb 25 '25±13.4%→+8.4%×0.62
Jan 13 '25±11.2%→−1.3%×0.12
Nov 6 '24±15.0%→+7.7%×0.51
Aug 14 '24±12.6%→−11.3%×0.90
pale = implied the day beforeink = the next day's close× = realized ÷ implied
2-quarter memory
Q1 FY26 · reported -0.09 · rev $105M
record note
The note composes when the report lands. Nothing is written for a quarter that hasn't been read.